We believe that point-of-care molecular diagnostics should directly link rapid detection to treatment during a patient visit.
Value of POC Diagnostics
Point of care testing adds value by providing rapid turn-around of actionable results directly to treating physicians during the patient visit. Moving some infectious disease testing from the central lab to point of care has the potential to improve quality of care while reducing costs. Rapid detection may lead to better decisions for patient treatment and management and, more importantly, better outcomes.
The ClariLight™ platform revolutionizes point of care testing by delivering molecular diagnostic accuracy in a CLIA-waivable format. Lucigen has developed an instrument and disposable cartridge system that automates all laboratory processes. This allows meaningful diagnostic testing to be carried out by untrained healthcare staff.
Lucigen has developed LAMP nucleic-acid amplification methods for DNA and RNA targets. Our method eliminates traditional sample prep, delivers results in 30 minutes, and is able to process 16 individual tests from a single patient sample. These methods are for investigational use only; the performance characteristics of these methods have not yet been established. Read more